Shanghai Oriental Hospital Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Shanghai China (1920)

Organization Overview

First Clinical Trial
2018
NCT04941339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Affiliation: Shanghai Oriental Hospital | Shanghai Oriental hospital | Shanghai Oriental Hospital | Shanghai Oriental Hospital ,China | Shanghai Orient Hospital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 14
  • # of Trial APIs: 14